192 related articles for article (PubMed ID: 19232014)
1. The effect of prostaglandin analogs and prostamide on central corneal thickness.
Hatanaka M; Vessani RM; Elias IR; Morita C; Susanna R
J Ocul Pharmacol Ther; 2009 Feb; 25(1):51-3. PubMed ID: 19232014
[TBL] [Abstract][Full Text] [Related]
2. The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness.
Zhong Y; Shen X; Yu J; Tan H; Cheng Y
Cornea; 2011 Aug; 30(8):861-4. PubMed ID: 21499083
[TBL] [Abstract][Full Text] [Related]
3. [Prostaglandin analogues and central corneal thickness].
Stefan C; Dumitrica DM; Tebeanu E; Nae I; Sapundgieva A; Dragomir L
Oftalmologia; 2007; 51(4):95-9. PubMed ID: 18543683
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of latanoprost and bimatoprost on central corneal thickness.
Sen E; Nalcacioglu P; Yazici A; Aksakal FN; Altinok A; Tuna T; Koklu G
J Glaucoma; 2008 Aug; 17(5):398-402. PubMed ID: 18703951
[TBL] [Abstract][Full Text] [Related]
5. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
[TBL] [Abstract][Full Text] [Related]
6. The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: a 2-year study on 129 eyes.
Bafa M; Georgopoulos G; Mihas C; Stavrakas P; Papaconstantinou D; Vergados I
Acta Ophthalmol; 2011 Aug; 89(5):448-51. PubMed ID: 19878123
[TBL] [Abstract][Full Text] [Related]
7. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.
Arcieri ES; Pierre Filho PT; Wakamatsu TH; Costa VP
Eye (Lond); 2008 Feb; 22(2):179-83. PubMed ID: 16936646
[TBL] [Abstract][Full Text] [Related]
8. Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma.
Harasymowycz PJ; Papamatheakis DG; Ennis M; Brady M; Gordon KD;
Cornea; 2007 Jan; 26(1):34-41. PubMed ID: 17198011
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.
Koz OG; Ozsoy A; Yarangumeli A; Kose SK; Kural G
Acta Ophthalmol Scand; 2007 Dec; 85(8):838-43. PubMed ID: 17680841
[TBL] [Abstract][Full Text] [Related]
10. Effects of topical prostaglandin therapy on corneal layers thickness in primary open-angle glaucoma patients using anterior segment optical coherence tomography.
Eraslan N; Celikay O
Int Ophthalmol; 2023 Sep; 43(9):3175-3184. PubMed ID: 37067694
[TBL] [Abstract][Full Text] [Related]
11. Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension.
Crichton AC; Vold S; Williams JM; Hollander DA
Adv Ther; 2013 Mar; 30(3):260-70. PubMed ID: 23475405
[TBL] [Abstract][Full Text] [Related]
12. Switching efficacy on intraocular pressure from latanoprost to bimatoprost in eyes with open angle glaucoma: implication to the changes of central corneal thickness.
Sawada A; Yamamoto T
Jpn J Ophthalmol; 2014 Sep; 58(5):423-8. PubMed ID: 25004992
[TBL] [Abstract][Full Text] [Related]
13. The influence of central corneal thickness on response to topical prostaglandin analogue therapy.
Birt CM; Buys YM; Kiss A; Trope GE;
Can J Ophthalmol; 2012 Feb; 47(1):51-4. PubMed ID: 22333852
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study.
Cellini M; Caramazza R; Bonsanto D; Bernabini B; Campos EC
Ophthalmologica; 2004; 218(5):312-7. PubMed ID: 15334011
[TBL] [Abstract][Full Text] [Related]
15. [Bimatoprost therapy in glaucoma].
Călugăru D; Călugăru M
Oftalmologia; 2009; 53(3):34-45. PubMed ID: 19899545
[TBL] [Abstract][Full Text] [Related]
16. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
Arcieri ES; Santana A; Rocha FN; Guapo GL; Costa VP
Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma.
Faridi UA; Saleh TA; Ewings P; Venkateswaran M; Cadman DH; Samarasinghe RA; Vodden J; Claridge KG
Clin Exp Ophthalmol; 2010 Oct; 38(7):678-82. PubMed ID: 20456437
[TBL] [Abstract][Full Text] [Related]
18. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Li N; Chen XM; Zhou Y; Wei ML; Yao X
Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
[TBL] [Abstract][Full Text] [Related]
19. Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.
Berenson KL; Kymes S; Hollander DA; Fiscella R; Burk C; Patel VD
Am J Manag Care; 2011 Sep; 17(9):e365-74. PubMed ID: 21902444
[TBL] [Abstract][Full Text] [Related]
20. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.
Reardon G; Schwartz GF; Mozaffari E
Clin Ther; 2003 Apr; 25(4):1172-85. PubMed ID: 12809964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
